Akoya Biosciences Inc AKYA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AKYA is a good fit for your portfolio.
News
-
Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences
-
Akoya Biosciences Reports First Quarter 2024 Financial Results
-
Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
-
Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
-
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
-
Akoya Biosciences Shares Jump on 2024 Outlook, Thermo Fisher Deal
Trading Information
- Previous Close Price
- $2.44
- Day Range
- $2.43–2.50
- 52-Week Range
- $1.88–7.06
- Bid/Ask
- $2.35 / $2.53
- Market Cap
- $121.49 Mil
- Volume/Avg
- 104,409 / 348,412
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.24
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler® (formerly CODEX) and PhenoImager® (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 330
- Website
- https://www.akoyabio.com
Comparables
Valuation
Metric
|
AKYA
|
BNGO
|
TECH
|
---|---|---|---|
Price/Earnings (Normalized) | — | — | 43.80 |
Price/Book Value | 3.71 | 0.44 | 6.30 |
Price/Sales | 1.24 | 0.67 | 11.25 |
Price/Cash Flow | — | — | 40.89 |
Price/Earnings
AKYA
BNGO
TECH
Financial Strength
Metric
|
AKYA
|
BNGO
|
TECH
|
---|---|---|---|
Quick Ratio | 2.26 | 1.04 | 2.49 |
Current Ratio | 3.07 | 1.46 | 4.08 |
Interest Coverage | −6.68 | −43.61 | 14.52 |
Quick Ratio
AKYA
BNGO
TECH
Profitability
Metric
|
AKYA
|
BNGO
|
TECH
|
---|---|---|---|
Return on Assets (Normalized) | −32.09% | −59.94% | 10.95% |
Return on Equity (Normalized) | −104.58% | −90.03% | 14.98% |
Return on Invested Capital (Normalized) | −38.24% | −74.32% | 12.39% |
Return on Assets
AKYA
BNGO
TECH
Medical Instruments & Supplies Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
Intuitive Surgical Inc
ISRG
| Yryhnwgxnz | Bffcv | $156.8 Bil | |||
Becton Dickinson & Co
BDX
| Gwrdgwb | Dgzqnj | $68.6 Bil | |||
Alcon Inc
ALC
| Brpvgrr | Tvlzdr | $46.5 Bil | |||
Coloplast A/S ADR
CLPBY
| Sptzyqxdf | Mqy | $29.1 Bil | |||
ResMed Inc
RMD
| Hhfbdmscwz | Kwhcbn | $28.9 Bil | |||
West Pharmaceutical Services Inc
WST
| Mdwttwmmh | Hzct | $20.7 Bil | |||
The Cooper Companies Inc
COO
| Wzhddtbz | Byzlxd | $18.6 Bil | |||
Hologic Inc
HOLX
| Wrxdwqnr | Dggljq | $18.4 Bil | |||
Baxter International Inc
BAX
| Hrxxzzzx | Txndjq | $18.1 Bil | |||
Teleflex Inc
TFX
| Llpj | Wxjnc | $10.4 Bil |